SEC Form 4 · accession 0001144204-17-013286
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Wirostko
Officer — Chief Medical Officer
Period of report
Mar 7, 2017
Accepted (ET)
Mar 7, 2017 · 5:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 7, 2017 | A | 8,700 | $2.83 | A | 217,842 | D | |
| Common Stock | holding | — | — | — | 41,700 | I | By husband |
Table II — derivative securities
No Table II lines on this filing.